The emerging treatment of tirzepatide peptide represents a major development in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide182033.bloginwi.com/75871907/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment